Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Kite Pharma

Kite Wins EMA Recommendation To Market Tecartus For Leukemia Patients

The European Medicines Agency has recommended new uses for six approved products, including the CAR T-cell therapy Tecartus. 

Cancer Approvals

EU Approval Decision Imminent For First CD20xCD3 Bispecific Antibody

If Roche gets the nod from the European Medicines Agency for mosunetuzumab this week, it could become the first company to market a CD20xCD3 bispecific antibody for follicular lymphoma.

Europe Approvals

Proactive US FDA Propelled Review Of Genentech’s Actemra In Systemic Sclerosis Amid Evolving Regulatory Landscape

Pink Sheet’s Drug Review Profile series looks at the unusual history of a systemic sclerosis interstitial lung disease indication for Genentech’s Actemra that was revived at the FDA’s behest and vetted by CDER’s high-level CDER policy council.

Drug Review Profile Approvals

CAR-T Manufacturing: Guidance Anticipates Platform Challenges And Opportunities

Draft from US FDA advises sponsors on how to draw from platform knowledge, while anticipating issues associated with emerging centralized and distributed manufacturing approaches for autologous and allogeneic products and their viral vectors.

Manufacturing Gene Therapy
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register